Law360, Washington (November 22, 2011, 3:29 PM ET) -- Mylan Pharmaceuticals Inc. sought to convince the Federal Circuit on Tuesday to overturn an injunction barring it from manufacturing a generic version of Warner Chilcott LLC's oral antibiotic Doryx pending a lower court's ruling on Warner's infringement claims.
Warner Chilcott filed suit in May 2009, claiming Mylan's plans to market a generic Doryx in 150-milligram delayed-release tablets infringed its patent for the drug, which is used to treat acne. In September, U.S. District Judge William Martini granted Warner's request for a preliminary injunction, finding the Irish...
Mylan Asks Fed Circ. To End Doryx ANDA Injunction
To view the full article, take a free trial now.
